Guangdong Lifestrong Pharmacy Co., Ltd.
SZSE:301111.SZ
18.89 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 159.101 | 131.109 | 179.213 | 485.349 | 108.131 | 74.202 | 93.989 | 94.985 |
| Short Term Investments
| 34.814 | 72.858 | 81.321 | 48.038 | 26.289 | 27.626 | 0 | 0 |
| Cash and Short Term Investments
| 193.915 | 203.968 | 260.534 | 533.387 | 134.42 | 101.828 | 93.989 | 94.985 |
| Net Receivables
| 87.914 | 77.337 | 177.502 | 0 | 81.301 | 86.977 | 68.628 | 33.851 |
| Inventory
| 90.132 | 83.434 | 70.689 | 51.912 | 55.262 | 59.815 | 57.581 | 65.68 |
| Other Current Assets
| 143.236 | 142.757 | 92.222 | 3.615 | 43.597 | 32.738 | 8.878 | 16.85 |
| Total Current Assets
| 515.196 | 509.656 | 600.948 | 708.843 | 283.045 | 251.324 | 227.063 | 209.14 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 115.241 | 58.586 | 55.937 | 74.546 | 91.482 | 61.538 | 58.494 | 61.096 |
| Goodwill
| 7.322 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 29.882 | 30.183 | 7.827 | 7.891 | 8.092 | 8.523 | 8.72 | 8.784 |
| Goodwill and Intangible Assets
| 37.204 | 30.183 | 7.827 | 7.891 | 8.092 | 8.523 | 8.72 | 8.784 |
| Long Term Investments
| 156.261 | 165.22 | 99.955 | -14.568 | 99.574 | 0 | -0 | 0 |
| Tax Assets
| 13.915 | 8.508 | 8.519 | 1.22 | 1.158 | 1.871 | 2.244 | 1.12 |
| Other Non-Current Assets
| 95.35 | 83.383 | 83.878 | 48.266 | -99.574 | 2 | 1.085 | 0.774 |
| Total Non-Current Assets
| 417.97 | 345.879 | 256.116 | 117.355 | 100.732 | 73.932 | 70.543 | 71.775 |
| Total Assets
| 933.167 | 855.535 | 857.063 | 826.198 | 383.776 | 325.256 | 297.606 | 280.915 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 55.996 | 34.869 | 29.035 | 37.588 | 26.201 | 17.167 | 28.793 | 32.111 |
| Short Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 46.7 |
| Tax Payables
| 6.856 | 5.114 | 19.081 | 8.334 | 3.602 | 6.921 | 13.884 | 5.93 |
| Deferred Revenue
| 0 | 0 | 60.711 | 26.801 | 4.807 | 13.385 | 15.083 | 11.502 |
| Other Current Liabilities
| 32.001 | 25.984 | 18.365 | 14.493 | 18.28 | 21.888 | 22.672 | 29.465 |
| Total Current Liabilities
| 94.854 | 65.968 | 93.356 | 66.077 | 48.084 | 45.976 | 65.349 | 114.206 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 70.86 | 10.087 | 0 | 0.159 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0.702 | 1.276 | 5.036 | 7.452 | 9.212 | 7.502 | 2.29 | 0.342 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 1.656 | 3.074 | 0.094 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 71.562 | 11.362 | 5.036 | 9.267 | 12.287 | 7.596 | 2.29 | 0.342 |
| Total Liabilities
| 166.416 | 77.33 | 98.392 | 75.344 | 60.37 | 53.572 | 67.638 | 114.548 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 160 | 160 | 160 | 160 | 120 | 120 | 120 | 10 |
| Retained Earnings
| 163.174 | 177.885 | 163.971 | 161.311 | 109.055 | 63.446 | 31.961 | 22.371 |
| Accumulated Other Comprehensive Income/Loss
| 0 | -0 | 33.414 | 28.255 | 94.351 | 88.238 | 78.007 | 0 |
| Other Total Stockholders Equity
| 441.163 | 438.29 | 401.289 | 401.287 | 94.351 | 88.238 | 78.017 | 133.995 |
| Total Shareholders Equity
| 764.337 | 776.175 | 758.671 | 750.854 | 323.406 | 271.684 | 229.967 | 166.367 |
| Total Equity
| 766.751 | 778.205 | 758.671 | 750.854 | 323.406 | 271.684 | 229.967 | 166.367 |
| Total Liabilities & Shareholders Equity
| 933.167 | 855.535 | 857.063 | 826.198 | 383.776 | 325.256 | 297.606 | 280.915 |